Seroatlas · Human Serome Atlas

IYD

Iodotyrosine deiodinase 1

Also known as: C6orf71, DEHAL1, dJ422F24.1, IYD1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6PHW0
Gene
IYD
Ensembl
ENSG00000009765
Chromosome
6
Canonical length
289 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins
Subcellular location
Plasma membrane
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes an enzyme that catalyzes the oxidative NADPH-dependent deiodination of mono- and diiodotyrosine, which are the halogenated byproducts of thyroid hormone production. The N-terminus of the protein functions as a membrane anchor. Mutations in this gene cause congenital hypothyroidism due to dyshormonogenesis type 4, which is also referred to as deiodinase deficiency, or iodotyrosine dehalogenase deficiency, or thyroid hormonogenesis type 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]

Canonical amino-acid sequenceUniProt

289 residues, UniProt reviewed canonical sequence.

>Q6PHW0|IYD
     1  MYFLTPILVA ILCILVVWIF KNADRSMEKK KGEPRTRAEA RPWVDEDLKD SSDLHQAEED
    61  ADEWQESEEN VEHIPFSHNH YPEKEMVKRS QEFYELLNKR RSVRFISNEQ VPMEVIDNVI
   121  RTAGTAPSGA HTEPWTFVVV KDPDVKHKIR KIIEEEEEIN YMKRMGHRWV TDLKKLRTNW
   181  IKEYLDTAPI LILIFKQVHG FAANGKKKVH YYNEISVSIA CGILLAALQN AGLVTVTTTP
   241  LNCGPRLRVL LGRPAHEKLL MLLPVGYPSK EATVPDLKRK PLDQIMVTV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against IYD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.37
Highest tissue expression
442 nTPM

Expression across tissuesHPA

Tissue

  • thyroid gland: 442 nTPM
  • liver: 31 nTPM
  • kidney: 25 nTPM
  • small intestine: 19 nTPM
  • duodenum: 17 nTPM
  • gallbladder: 8.3 nTPM

Single-cell type

  • enterocytes: 102 nCPM
  • proximal tubule cells: 99 nCPM
  • hepatocytes: 36 nCPM
  • goblet cells: 33 nCPM
  • colonocytes: 26 nCPM
  • gastric progenitor cells: 24 nCPM

Immune cell

  • neutrophil: 2 nTPM
  • basophil: 1.6 nTPM
  • total PBMC: 1.3 nTPM
  • NK-cell: 0.7 nTPM
  • classical monocyte: 0.5 nTPM
  • intermediate monocyte: 0.4 nTPM

Brain region

  • pons: 4.3 nTPM
  • cerebellum: 4.2 nTPM
  • thalamus: 4.2 nTPM
  • cerebral cortex: 4 nTPM
  • white matter: 4 nTPM
  • hippocampal formation: 3.8 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about IYD.

Disease | AllUniProt

Conditions IYD is implicated in, by any mechanism.

Disease | GeneticClinVar

8 pathogenic / likely-pathogenic of 110 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.88
gnomAD pLI
0
gnomAD missense Z
0.24
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Nitroreductase-like
  • Nitroreductase
  • Nitroreductase/BluB
  • Nitroreductase family

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads IYD as an antibody target. Whether an autoantibody or antibody against IYD could matter depends on whether native IYD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

IYD is annotated at the cell surface, where native IYD is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label IYD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/IYD. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...